Board of Trustees
The Board of Trustees of Biocat is the highest governing body of the foundation and brings together a diverse representation of public and private entities committed to advancing the life sciences sector in Catalonia.
Biocat
- Presentation
- Welcome
- 2025 in perspective: a year of strategic execution
- Acceleration, training, transfer and innovation access to the healthcare system
- Programa PASS: finalización del programa piloto, Jornada PASS y lanzamiento de la primera convocatoria INNOPASS
- 8th edition of CRAASH Barcelona program
- 4th edition of Tech Transfer Day
- Health Investment Portal launched
- 10th edition of d·HEALTH Barcelona
- Participation in BREATH and BRIDGE European projects
- Other acceleration, transfer and investment initiatives with Biocat support and/or collaboration
- Development of the advanced therapies hub
- The BioRegion’s international projection and Biocat’s influence
- Acceleration, training, transfer and innovation access to the healthcare system
- Biocat
Biocat Board of Trustees, 2025
- The Right Honourable Mr Salvador Illa i Roca, President of the Government of Catalonia and Chair of the Biocat Board of Trustees
- The Honourable Ms Olga Pané Mena, Minister for Health and First Vice-Chair of the Biocat Board of Trustees
- The Honourable Ms Alícia Romero Llano, Minister for Economy and Finance
- The Honourable Ms Núria Montserrat Pulido, Minister for Research and Universities
- The Honourable Mr Miquel Sàmper Rodríguez, Minister for Business and Labour
- The Honourable Mr Òscar Ordeig i Molist, Minister for Agriculture, Livestock, Fisheries and Food
- The Most Illustrious Mr Jordi Valls Riera, Representative of Barcelona City Council and Fourth Deputy Mayor
- Mr Ignasi Biosca i Reig, Representative of Catalonia.Health, CEO of Laboratoris Reig Jofré and Second Vice-Chair of the Biocat Board of Trustees
- Ms Fina Lladós Canela, Representative of Farmaindustria, President of Farmaindustria and Managing Director of Amgen
- Mr Ricardo Rafael Suárez, Representative of Farmaindustria, President of AstraZeneca Farmacéutica Spain
- Ms Lídia Martín Pereda, Representative of Farmaindustria, General Manager of Almirall
- Mr David Solanes López, Representative of Farmaindustria, Managing Director of Laboratorios Ern
- Ms Raquel Tapia Rodríguez, Representative of Farmaindustria, General Manager of Sanofi-Aventis
- Ms Mariona Serra Pagès, Representative of Catalonia.Health, President of Catalonia.Health and Co-founder and CEO of GoodGut
- Mr Joan Puig de Dou, Representative of Catalonia.Health, Vice-President of Catalonia.Health and CEO of Kymos Pharma Services
- Mr Marc Pérez Pey, Representative of Fenin Catalunya, Vice-President for Western Europe and Africa at the HARTMANN Group
- Mr Albert Giralt Cadevall, Representative of Fenin Catalunya, Managing Director of the Avinent Group
- Ms Georgina Sorrosal de Luna, Representative of the Barcelona Medical Association, Director of the Innovation and Entrepreneurship Area at the Barcelona Medical Association
- Rector Magnifica Ms Laia de Nadal, Representative of the Catalan Association of Public Universities, Rector Magnifica of Pompeu Fabra University
- Mr Francesc Posas Garriga, Representative of the Catalan Association of Research Entities, Director of the Institute for Research in Biomedicine (IRB)
- Mr Josep M. Campistol Plana, Representative of Catalonia’s research-intensive hospitals, Managing Director of Hospital Clínic Barcelona
- Ms Maria Terrades Palomar, Representative of the Catalan Network of Science and Technology Parks, Director of Barcelona Science Park
- Mr Lluís García Pareras, Founder and Managing Partner at Invivo Capital
- Mr Àngel Font Vidal, Executive Director of the CaixaResearch Institute
- Mr Alberto Ouro, Secretary of the Biocat Board of Trustees, Partner in the Innovation and Entrepreneurship Department at RCD
Sign up for our newsletters
Stay up-to-date on the latest news, events and trends in the BioRegion.
You can unsubscribe at any time.
For more information, see our Privacy Policy.
For more information, see our Privacy Policy.
